Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-17-000017
Filing Date
2017-05-05
Accepted
2017-05-04 17:43:35
Documents
85
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20170331x10q.htm 10-Q 979109
2 EXHIBIT 10.1 ex03312017101.htm EX-10.1 19396
3 EXHIBIT 10.2 ex03312017102.htm EX-10.2 19639
4 EXHIBIT 10.3 ex03312017103.htm EX-10.3 22214
5 EXHIBIT 31.1 ex03312017311.htm EX-31.1 18468
6 EXHIBIT 31.2 ex03312017312.htm EX-31.2 18548
7 EXHIBIT 32.1 ex03312017321.htm EX-32.1 11098
8 EXHIBIT 32.2 ex03312017322.htm EX-32.2 11264
15 productpipelinechart.jpg GRAPHIC 68986
  Complete submission text file 0001438533-17-000017.txt   5903509

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rtrx-20170331.xml EX-101.INS 1133477
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20170331.xsd EX-101.SCH 51988
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20170331_cal.xml EX-101.CAL 84413
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20170331_def.xml EX-101.DEF 240135
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20170331_lab.xml EX-101.LAB 625808
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20170331_pre.xml EX-101.PRE 359309
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 17815439
SIC: 2834 Pharmaceutical Preparations